CM
PODD icon

Crestline Management’s Insulet PODD Stock Holding History

Crestline Management’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,849
Closed -$1.29M – 314
2021
Q4 		$1.29M Sell
4,849
-3,940
-45% -$1.14M 0.1% 135
2021
Q3 		$2.5M Buy
+8,789
New +$2.51M 0.23% 95

Other funds holding PODD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCP
D1 Capital Partners New York $34.8B AUM 11.34% 1-Year Est. Return

Crestline Management's PODD Position: Q1 2022 in Review

Crestline Management sold out of Insulet (PODD) in Q1 2022, closing a stake of 4,849 shares — an estimated $1.29M sold.

Crestline Management first reported a position in PODD in Q3 2021 and held it in 2 quarters. The position peaked at $2.5M in Q3 2021. 483 funds tracked by Wall St. Rank hold PODD as of Q1 2022.

  • Crestline Management reported no remaining Insulet position as of Q1 2022 after selling out during the quarter.
  • Crestline Management sold 4,849 Insulet shares in Q1 2022, an estimated $1.29M.
  • Crestline Management first reported a position in Insulet in Q3 2021 and held it in 2 quarters.
  • Crestline Management's Insulet position peaked at $2.5M in Q3 2021.
  • 483 funds tracked by Wall St. Rank held Insulet as of Q1 2022.

Based on Crestline Management's 13F filing for Q1 2022, filed 16 May 2022.